Reappraisal of the papillary urothelial neoplasm of low malignant potential (PUNLMP)

Histopathology - Tập 77 Số 4 - Trang 525-535 - 2020
Timothy D. Jones1, Liang Cheng2,3
1Department of Pathology, Norton Healthcare/CPA Laboratory, Louisville, KY, USA
2Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, USA
3Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA

Tóm tắt

Although the papillary urothelial neoplasm of low malignant potential (PUNLMP) diagnostic category was retained in the updated 2016 World Health Organisation (WHO) classification of tumours of the urinary system, there still exists a great deal of controversy regarding the biological behaviour of these tumours. We review PUNLMP tumours and histological grading with an emphasis on the histomorphological, genetic and clinical similarities between PUNLMP and low‐grade non‐invasive papillary urothelial carcinoma. A literature search using PubMed was performed. All relevant literature concerning PUNLMP and the grading of urothelial tumours was reviewed. PUNLMPs cannot be reliably distinguished from low‐grade non‐invasive papillary urothelial carcinomas based on the histomorphological criteria outlined in the WHO 2004/2016 classification system. PUNLMPs and low‐grade non‐invasive papillary urothelial carcinomas are not only morphologically similar, but also share similar molecular genetic alterations and a similar risk of recurrence and progression. In addition, there are no consensus recommendations for a different method of treatment and follow‐up for these two tumour types. Attempting to distinguish PUNLMP from low‐grade papillary urothelial carcinoma adds an unnecessary level of complexity to the grading and classification of urothelial tumours. We feel that PUNLMP terminology should be abandoned and that all such tumours should be classified as low‐grade carcinomas until more objective determinants of clinical outcome can be established.

Từ khóa


Tài liệu tham khảo

10.1097/00000478-199812000-00001

Eble JN, 2004, World Health Organization classification of tumours of the urinary system and male genital organs

Moch H, 2016, World Health Organization classification of tumours of the urinary system and male genital organs

10.1016/S0022-5347(06)00267-9

10.1002/9781118275436

10.1016/j.eururo.2019.08.016

10.1016/j.juro.2016.06.049

10.1016/j.urolonc.2019.10.002

Mostofi FK, 1973, Histological typing of urinary bladder tumors. International classification of tumors 19

10.1371/journal.pone.0083192

10.1016/j.eururo.2006.10.037

10.1016/j.humpath.2012.01.008

10.1016/j.eururo.2009.03.052

10.1007/s00428-003-0905-0

10.1016/S0022-5347(05)64553-3

Bosschieter J, 2018, Reproducibility and prognostic performance of the 1973 and 2004 World Health Organization classifications for grade in non‐muscle‐invasive bladder cancer: a multicenter study in 328 bladder tumors, Clin. Genitourin. Cancer, 16, e985, 10.1016/j.clgc.2018.05.002

10.1016/j.eururo.2017.04.015

10.1097/01.ju.0000055471.78783.ae

Yorukoglu K, 2010, Re: Matthias May Sabine Brookman‐Amissah Jan Roigas et al. Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organization classifications, Eur. Urol., 57, 850, 10.1016/j.eururo.2009.03.052

10.1038/modpathol.2009.1

10.1007/s00428-011-1072-3

10.1016/j.eururo.2009.09.022

10.1002/(SICI)1097-0142(19991115)86:10<2102::AID-CNCR31>3.0.CO;2-U

10.1016/S0090-4295(02)01705-3

10.1016/S0022-5347(05)66443-9

10.1016/j.euf.2018.01.003

10.1046/j.1464-410X.2003.04415.x

Kim KH, 2019, The association of a number of predictive factors for the recurrence of papillary urothelial neoplasm of low malignant potential: prognostic analysis from multiple academic centers, Urol. J., 16, 558

10.1186/s13000-015-0234-z

10.1136/jcp.55.12.900

10.1309/AJCP12MRVVHTCKEJ

10.1002/cncr.10733

10.1002/(SICI)1097-0142(20000401)88:7<1663::AID-CNCR21>3.0.CO;2-8

10.1159/000080828

10.1016/j.juro.2013.11.056

10.1111/his.13063

10.1007/978-3-319-22864-8

Bosschieter J, 2019, Objectifying grade in Ta‐T1 urothelial carcinomas of the bladder using proliferative and quantitative markers: a multicentre study in 310 bladder tumors, Urol. Oncol., 37, 530.e531, 10.1016/j.urolonc.2019.03.002

10.1016/j.eururo.2015.02.021

10.1002/path.4886

10.1111/his.13734

10.1200/JCO.2003.05.073

10.1007/s00428-017-2164-5

10.1158/1541-7786.MCR-16-0003

10.1016/j.eururo.2016.12.008

10.1111/his.13441

10.1016/j.humpath.2013.10.034

Montironi R, 2007, Chromatin phenotype karyometry can predict recurrence in papillary urothelial neoplasms of low malignant potential, Cell. Oncol., 29, 47

10.1136/jcp.2004.017608

10.1016/j.anndiagpath.2017.12.007